» Articles » PMID: 36689399

The Effect of Contraceptive Access Reform on Privately Insured Patients: Evidence from Delaware Contraceptive Access Now

Overview
Journal PLoS One
Date 2023 Jan 23
PMID 36689399
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Many states are implementing comprehensive programs aimed at reducing persistent barriers to contraceptive care. Evidence on the effectiveness of these programs is essential for practice improvement and policy development.

Objective: To evaluate changes in the probability of initiating a contraceptive method by women with employer sponsored insurance after implementation of Delaware Contraceptive Access Now (DelCAN), a statewide initiative that aimed to increase access to long-acting reversible contraceptives (LARCs).

Design, Setting, And Participants: We used a difference-in-differences design to examine contraceptive initiation rates. Data came from IBM Marketscan and covered women age 15-44 enrolled in employer sponsored insurance. The primary outcome was insertion of a LARC, both in the overall study population and in the immediate postpartum (IPP) setting. Secondary analysis examined changes to other contraceptive method types.

Results: The cohort of 4,550,459 enrollees generated a sample of 11,888,837 person-years and 615,670 childbirth hospitalizations. Difference-in-differences estimates suggested that DelCAN was associated with a 0.3 percentage point (95% CI [0.2, 0.5], p<0.001) increase in the LARC insertion rate in the overall study population and a 0.4 percentage point increase (95% CI [0.2, 0.6], p<0.001) in the percent of births adopting IPP LARC. Associations between DelCAN and LARC insertion appeared stronger for adolescents compared to older women. Results for other method types were less consistent.

Conclusions: A comprehensive statewide program was associated with increased LARC insertion rates among enrollees with employer sponsored insurance. Understanding the effect of these programs is critical for on-going policy development for states engaged in contraceptive access reform.

Citing Articles

Examining the impact of Medicaid payments for immediate postpartum long-acting reversible contraception on the mental health of low-income mothers.

Marthey D, Rochford H, Andreyeva E Health Serv Res. 2024; 59(3):e14281.

PMID: 38205665 PMC: 11063096. DOI: 10.1111/1475-6773.14281.


Contraceptive access reform and abortion: Evidence from Delaware.

Kim T, Marthey D, Boudreaux M Health Serv Res. 2023; 58(4):781-791.

PMID: 37032478 PMC: 10315387. DOI: 10.1111/1475-6773.14156.

References
1.
Austin P . Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med. 2009; 28(25):3083-107. PMC: 3472075. DOI: 10.1002/sim.3697. View

2.
Marthey D, Rashid H, Xie L, Boudreaux M . An evaluation of the Be Your Own Baby public awareness campaign. Health Serv Res. 2021; 56(5):766-776. PMC: 8522570. DOI: 10.1111/1475-6773.13698. View

3.
Malcolm N, Patterson K, Pliska E, Akbarali S, Moskosky S, Hart J . Scaling Up Evidence-Based Practices in Contraceptive Access Initiatives. Am J Public Health. 2022; 112(S5):S473-S477. PMC: 10461489. DOI: 10.2105/AJPH.2022.306824. View

4.
Steenland M, Pace L, Cohen J . Association of Medicaid Reimbursement for Immediate Postpartum Long-acting Reversible Contraception With Infant Birth Outcomes. JAMA Pediatr. 2022; 176(3):296-303. PMC: 8749696. DOI: 10.1001/jamapediatrics.2021.5688. View

5.
Stanek A, Bednarek P, Nichols M, Jensen J, Edelman A . Barriers associated with the failure to return for intrauterine device insertion following first-trimester abortion. Contraception. 2009; 79(3):216-20. DOI: 10.1016/j.contraception.2008.09.003. View